Hepatitis Monthly

Published by: Kowsar

High Prevalence of Hepatitis B Virus Infection in the Village of Esfandiar in South Khorasan Province, Iran

Davod Javanmard 1 , 2 , Seyed Moayed Alavian 3 , Farshid Abedi 1 , Mohammad Hasan Namaei 1 , Arghavan Asghari 1 and Masood Ziaee 1 , *
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
Article information
  • Hepatitis Monthly: August 2018, 18 (8); e65473
  • Published Online: August 4, 2018
  • Article Type: Research Article
  • Received: December 23, 2017
  • Revised: July 15, 2018
  • Accepted: July 24, 2018
  • DOI: 10.5812/hepatmon.65473

To Cite: Javanmard D, Alavian S M, Abedi F, Namaei M H, Asghari A, et al. High Prevalence of Hepatitis B Virus Infection in the Village of Esfandiar in South Khorasan Province, Iran, Hepat Mon. 2018 ; 18(8):e65473. doi: 10.5812/hepatmon.65473.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. WHO. Hepatitis B fact sheet N°204 Geneva: world health organization. 2017, [cited updated July 2017]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 2. Ochola E, Ocama P, Orach CG, Nankinga ZK, Kalyango JN, McFarland W, et al. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health. 2013;13(1):727. doi: 10.1186/1471-2458-13-727. [PubMed: 23919752]. [PubMed Central: PMC3751632].
  • 3. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):74. doi: 10.4254/wjh.v4.i3.74.
  • 4. Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open. 2014;4(11). e005889. doi: 10.1136/bmjopen-2014-005889. [PubMed: 25387757]. [PubMed Central: PMC4244481].
  • 5. Hajarizadeh B, Mesgarpour B, Nasiri MJ, Alavian SM, Merat S, Poustchi H, et al. Estimating the Prevalence of Hepatitis B Virus Infection and Exposure Among General Population in Iran. Hepat Mon. 2017;17(8). doi: 10.5812/hepatmon.11715.
  • 6. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28(1):112-25. doi: 10.1093/epirev/mxj009. [PubMed: 16754644].
  • 7. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26(49):6266-73. doi: 10.1016/j.vaccine.2008.09.056. [PubMed: 18848855].
  • 8. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6. [PubMed: 18193122].
  • 9. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and risk factors for hepatitis B in an adult population: the first report from Birjand, south Khorasan, Iran. Hepatit Mon. 2016;16(9). doi: 10.5812/hepatmon.36452.
  • 10. Janahi EM. Prevalence and risk factors of hepatitis B virus infection in Bahrain, 2000 through 2010. PLoS One. 2014;9(2). e87599. doi: 10.1371/journal.pone.0087599. [PubMed: 24498341]. [PubMed Central: PMC3911996].
  • 11. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of hepatitis B virus infection and its risk factors in the west of Iran: a population-based study. Int J Prev Med. 2012;3(11):770-5. [PubMed: 23189228]. [PubMed Central: PMC3506088].
  • 12. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012;12(2):112-7. doi: 10.5812/hepatmon.822. [PubMed: 22509188]. [PubMed Central: PMC3321318].
  • 13. Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, Rostami S, et al. The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013;15(3):245-8. doi: 10.5812/ircmj.8200. [PubMed: 23984006]. [PubMed Central: PMC3745755].
  • 14. Ziaee M, Sharifzadeh G, Namaee MH, Fereidouni M. Prevalence of HIV and hepatitis B, C, D infections and their associated risk factors among prisoners in Southern Khorasan Province, Iran. Iran J Public Health. 2014;43(2):229-34. [PubMed: 26060747]. [PubMed Central: PMC4450691].
  • 15. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007;61(5):263-8. [PubMed: 17478956].
  • 16. Alavian SM, Tabatabaei SV, Nourizad S, Mansouri F, Khademi N, Amini Kafi-abad S, et al. Seroepidemiology of HBV infection in Kermanshah- west of Iran; a population based study. Jundishapur J Microbiol. 2012;5(4):564-9. doi: 10.5812/jjm.4156.
  • 17. Asl H, Kazem S, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in gypsy population residing Shahr-e-Kord. Arch Iran Med. 2004;7(1):20-2.
  • 18. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepatit Mon. 2016;16(4). doi: 10.5812/hepatmon.35577.
  • 19. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009;12(3):225-31. [PubMed: 19400598].
  • 20. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011;11(5):346-50. [PubMed: 22087159]. [PubMed Central: PMC3212777].
  • 21. Alswaidi FM, O'brien SJ. Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? Br J Prev Soc Med. 2010:jech-2009.
  • 22. Wurie IM, Wurie AT, Gevao SM. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med. 2005;24(1):18-20. [PubMed: 15909704].
  • 23. Sali S, Bashtar R, Alavian SM. Risk factors in chronic hepatitis B infection: a case-control study. Hepat Mon. 2005;2005(4, Autumn):109-15.
  • 24. Manfredi R. Occupational exposure and prevention guidelines in dental and stomatological settings - a literature review. Infectio. 2010;14(1):68-83. doi: 10.1016/s0123-9392(10)70094-1.
  • 25. Ducancelle A, Abgueguen P, Birguel J, Mansour W, Pivert A, Le Guillou-Guillemette H, et al. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS One. 2013;8(11). e80346. doi: 10.1371/journal.pone.0080346. [PubMed: 24265811]. [PubMed Central: PMC3827216].
  • 26. Moezzi M, Imani R, Khosravi N, Pourheidar B, Ganji F, Karimi A. Hepatitis B seroprevalence and risk factors in adult population of chaharmahal and bakhtiari province in 2013. Hepat Mon. 2014;14(5). doi: 10.5812/hepatmon.17389.
  • 27. Kassaian N, Ataei B, Javadi AA, Farajzadegan Z, Adibi P. Hepatitis B markers in Isfahan, Central Iran: a population-based study. Hepat Mon. 2009;2009(1, Winter):12-6.
  • 28. Kayvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F, et al. A population based study on hepatitis B virus in northern Iran, Amol. Hepat Mon. 2014;14(8). doi: 10.5812/hepatmon.20540.
  • 29. Ragheb M, Elkady A, Tanaka Y, Murakami S, Attia FM, Hassan AA, et al. Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt. J Med Virol. 2012;84(4):587-95. doi: 10.1002/jmv.23234. [PubMed: 22337297].
  • 30. Gunardi H, Iskandar MY, Ie SI, Dwipoerwantoro PG, Gani RA; Turyadi, et al. Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatol Int. 2017;11(1):96-104. doi: 10.1007/s12072-016-9764-z. [PubMed: 27624502].
  • 31. Alavian SM, Rajai M, Arab MS, Gashtasebifar S, Emadi V, Nejatbakhsh P. Viral hepatitis in iranian armed forces: prevalence of HBV and HCV in the wounded-in-action (WIA). Hepat Mon. 2005;5(4):129.
  • 32. Ishino Y, Ido K, Sugano K. Contamination with hepatitis B virus DNA in gastrointestinal endoscope channels: risk of infection on reuse after on-site cleaning. Endoscopy. 2005;37(6):548-51. doi: 10.1055/s-2005-861316. [PubMed: 15933928].
  • 33. Wu H, Shen B. Health care-associated transmission of hepatitis B and C viruses in endoscopy units. Clin Liver Dis. 2010;14(1):61-8. viii. doi: 10.1016/j.cld.2009.11.012. [PubMed: 20123440].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments